<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Neurol</journal-id>
      <journal-title-group>
        <journal-title>BMC Neurology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1471-2377</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27515947</article-id>
      <article-id pub-id-type="pmc">4982311</article-id>
      <article-id pub-id-type="publisher-id">660</article-id>
      <article-id pub-id-type="doi">10.1186/s12883-016-0660-x</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cerebral vasospasm and wernicke encephalopathy secondary to adult cyclic vomiting syndrome: the role of magnesium</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2134-4980</contrib-id>
          <name>
            <surname>S&#xE1;nchez-Larsen</surname>
            <given-names>&#xC1;lvaro</given-names>
          </name>
          <address>
            <phone>+34 967597100</phone>
            <email>aa.sanchezlarsen@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Segura</surname>
            <given-names>Tom&#xE1;s</given-names>
          </name>
          <address>
            <email>TSEGURAM@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Garc&#xED;a-Mu&#xF1;ozguren</surname>
            <given-names>Susana</given-names>
          </name>
          <address>
            <email>sugarmu@hotmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Peinado-R&#xF3;denas</surname>
            <given-names>Javier</given-names>
          </name>
          <address>
            <email>peinadillo@yahoo.es</email>
          </address>
          <xref ref-type="aff" rid="Aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zamarro</surname>
            <given-names>Joaqu&#xED;n</given-names>
          </name>
          <address>
            <email>joaquinzamarro@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hern&#xE1;ndez-Fern&#xE1;ndez</surname>
            <given-names>Francisco</given-names>
          </name>
          <address>
            <email>fco.hdez.fdez@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1">1</xref>
          <xref ref-type="aff" rid="Aff5">5</xref>
        </contrib>
        <aff id="Aff1"><label>1</label>Department of Neurology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain </aff>
        <aff id="Aff2"><label>2</label>Department of Neurology, Grupo Hospitales de Madrid, Madrid, Spain </aff>
        <aff id="Aff3"><label>3</label>Department of Radiology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain </aff>
        <aff id="Aff4"><label>4</label>Unit of Interventional Neuroradiology, Department of Radiology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain </aff>
        <aff id="Aff5"><label>5</label>Unit of Interventional Neuroradiology, Department of Radiology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>11</day>
        <month>8</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>16</volume>
      <elocation-id>135</elocation-id>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>4</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>2</day>
          <month>8</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s). 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Magnesium has a regulatory role in the excitability of cell membranes, and is also a cofactor in the phosphorylation of thiamine. Hypomagnesemia has been associated with coronary vasospasm, but its role in cerebrovascular pathology is controversial, and cerebral vasospasm exclusively attributable to hypomagnesemia has not been reported in humans.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We report the case of a 51-year-old man in whom uncontrollable vomiting, treatment with omeprazole and thiazide, and renal impairment lead to a severe hypomagnesemia (magnesium below the level of detection in blood tests), which secondarily caused Wernicke&#x2019;s encephalopathy and vasospasm in multiple cerebral arteries (seen with cerebral angiography and CT angiography) that presented with a complete right hemisphere neurological deficit. These disturbances completely resolved when magnesium levels were normalized and subsequent neuroimaging tests confirmed the resolution of angiographic changes.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Our case suggests that hypomagnesemia should be considered in the differential diagnosis of patients with neurological symptoms and predisposing causes.</p>
        </sec>
        <sec>
          <title>Electronic supplementary material</title>
          <p>The online version of this article (doi:10.1186/s12883-016-0660-x) contains supplementary material, which is available to authorized users.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Hypomagnesemia</kwd>
        <kwd>Wernicke encephalopathy</kwd>
        <kwd>Cerebral vasospasm</kwd>
        <kwd>Cyclic vomiting syndrome</kwd>
        <kwd>Case report</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Magnesium is the most abundant intracellular divalent cation and the fourth most abundant element in the body. The majority of this mineral is localized in the bones and soft tissues, only 1&#xA0;% resides in the extracellular fluids [<xref ref-type="bibr" rid="CR1">1</xref>]. Magnesium balance is maintained by means of intestinal absorption in the small bowel, mostly in the ileum and distal part of jejunum, and renal excretion. The kidneys are crucial in magnesium homeostasis. 70&#xA0;% of the magnesium filtered is reabsorbed in the thick ascending limb of the loop of Henle. It is estimated that an adult needs an intake of 255&#x2013;350&#xA0;mg daily [<xref ref-type="bibr" rid="CR1">1</xref>]. Conditions that can lead to hypomagnesemia include alcoholism, diabetes, malabsorption (Crohn&#x2019;s disease, ulcerative colitis, coeliac disease, short bowel syndrome), gastrointestinal loses (biliary or intestinal fistula, large-volume diarrhea or vomiting) endocrine causes (hyperaldosteronism, hyperparathyroidism, syndrome of inappropriate antidiuretic hormone secretion, hypercalcemia, hypercalciuria), renal disease (renal failure, dialysis, intrinsic tubular disorders) and medication use (diuretics, proton pump inhibitors, antibiotics, chemotherapeutic agents) [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
      <p>The principal function of magnesium in the human body is structural, mainly in bones and teeth. However, according to its ionic characteristics, it also plays a role in the regulation of the excitability of neuromuscular membranes. Magnesium works as a cofactor in many enzymatic reactions such as ATP kinase reactions or the activation of thiamine by its phosphorylation to thiamine pyrophosphate [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Magnesium is also an antagonist of the N-methyl-d-aspartate (NMDA) receptor [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>], and has direct vasodilatory effects due to various mechanisms. Hypomagnesemia is thought to lead to an increase in vascular smooth muscle tone and reactivity, its association with acute focal vasospasm in coronary arteries has been known for decades [<xref ref-type="bibr" rid="CR4">4</xref>], albeit cerebral vasospasm exclusively attributable to hypomagnesemia in humans has not been reported. We report a case of vasoconstriction in multiple cerebral arteries and Wernicke&#x2019;s encephalopathy (WE) secondary to hypomagnesemia.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 51-year-old man, diagnosed with adjustment disorder due to work problems, and hypertension without other vascular risk factors, non-smoker, no alcohol or drug consumption, treated with valsartan/hydrochlorothiazide and omeprazole. He presented with intermittent episodes of incoercible vomiting over a three month period, and was finally diagnosed with adult cyclic vomiting syndrome after an extensive study that ruled out organic origin (normal blood tests, stool test, urea breath test, abdominal CT scan and ultrasound, echoendoscopy with biopsies). The patient was admitted to hospital for prerenal kidney failure after several weeks of uncontrollable vomiting, up to 50 episodes per day. Physical examination was unremarkable except for intermittent optokinetic nystagmus. Blood tests showed creatinine 4.12&#xA0;mg/dL, urea 92&#xA0;mg/dL, creatinine clearance 15&#xA0;mL/min/S, albumin 4.6&#xA0;g/dL, Na 142&#xA0;mmol/L, K 3.3&#xA0;mmol/L, Cl 90&#xA0;mmol/L, Ca 7.6&#xA0;mg/dL (normal 8.6&#x2013;10.2), P 4&#xA0;mg/dL (normal 2.6&#x2013;4.5). Intravenous hydration and metoclopramide were started. 24&#xA0;h later he presented with a sudden and complete right-sided cerebral hemisphere deficit (National Institute of Health Stroke Scale [NIHSS] score of 18), without seizures, fever or other clinical features, and with a blood pressure of 146/93&#xA0;mmHg. Code Stroke was activated, ECG, brain CT scan and transcranial Doppler were normal and intravenous thrombolysis was decided upon. There was no improvement after 30&#xA0;min, and a CT angiography was performed (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a&#x2013;b</xref>) showing subtle narrowing of the entire right circulation, and stenoses in several branches of the right middle cerebral artery, making it impossible to rule out a distal vessel occlusion. Rescue therapy with mechanical thrombectomy was proposed, but cerebral angiography (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1c-d</xref>) showed several segments with stenosis without occlusion in multiple arteries of the right carotid circulation, so no therapeutic procedure was finally realized. There was no improvement after 24&#xA0;h, and the patient then developed a rapid progressive encephalopathy accompanied by visual hallucinations, ataxia, multidirectional nystagmus and ophthalmoparesis, symptoms in keeping with WE. Brain MRI was unremarkable (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1g-h</xref>, see also Additional files <xref rid="MOESM1" ref-type="media">1</xref>, <xref rid="MOESM2" ref-type="media">2</xref>, <xref rid="MOESM3" ref-type="media">3</xref> and <xref rid="MOESM4" ref-type="media">4</xref>), with no ischemic areas or other abnormalities. Further complete blood tests were conducted, and magnesium levels were found to be below the level of detection (&lt;0.5&#xA0;mg/dL, normal 1.5&#x2013;2.5), mild hypocalcaemia (6.6&#xA0;mg/dL) and hypophosphatemia (1.9&#xA0;mg/dL) were also observed. Diuretics, omeprazole and dextrose were stopped, intravenous ondansetron controlled the vomiting, and aggressive intravenous magnesium replacement, saline and empirical thiamine were commenced, and the patient was admitted to the intensive care unit to control potential cardiac arrhythmias. Blood tests after 24&#xA0;h showed almost normal calcium levels (8.5&#xA0;mg/dL) and a mild hypomagnesemia persisting (1.3&#xA0;mg/dL). In subsequent blood tests all ions were always in normal ranges. No cardiac abnormalities were apparent, and following analytical recovery the patient started to improve and within 48&#xA0;h the focal symptoms disappeared, and WE was completely resolved within two weeks. CT angiography carried out 7&#xA0;days after the beginning of symptom onset (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1e&#x2013;f</xref>) showed resolution of the arterial changes. Subsequent studies excluded renal tubular diseases (normal magnesium and other ions in 24&#x2013;hour urine), endocrine disorders (PTH and 25-hydroxy vitamin D normal) and in successive neuroimaging controls no new abnormalities were found. The patient remains neurologically asymptomatic.<fig id="Fig1"><label>Fig. 1</label><caption><p>Vasospasm in cerebral arteries secondary to hypomagnesemia. Coronal (<bold>a</bold>) and axial (<bold>b</bold>) CT angiography showing subtle focal changes in the vascular lumen of the right carotid circulation (<bold>a</bold>, white arrows) and overall decrease of the vascularization in the territory of the right middle cerebral artery (<bold>b</bold>, circled in white). Selective cerebral angiography injecting from the left internal carotid artery (<bold>c</bold>), without abnormalities, and from the right internal carotid artery (<bold>d</bold>), showing overall decrease of the vascularization, focal narrowing (<bold>d</bold>, white arrows) and segmental stenosis of several arteries (<bold>d</bold>, white box). CT angiography carried out 7&#xA0;days after the previous one (<bold>e</bold> and <bold>f</bold>) showing complete resolution of the vascular changes. Diffusion weighted imaging (DWI) (<bold>g</bold>) and fluid attenuation inversion recovery (FLAIR) (<bold>h</bold>) sequences of brain MRI showing no relevant abnormalities</p></caption><graphic xlink:href="12883_2016_660_Fig1_HTML" id="MO1"/></fig></p>
    </sec>
    <sec id="Sec3">
      <title>Conclusions</title>
      <p>Acute hypomagnesemia can produce different symptoms depending on the severity of the deficiency. Early signs of hypomagnesemia are non-specific and include loss of appetite, lethargy, nausea, vomiting, fatigue and weakness. The association with hypophosphatemia and hypocalcaemia is frequent. Subsequently, lower magnesium levels can result in tremor, muscle cramps, tetany and generalized seizures [<xref ref-type="bibr" rid="CR1">1</xref>]. On the other hand, chronic magnesium deficiency is not rare these days, however, it usually remains asymptomatic. This condition has been associated with anxiety, depression, other psychiatric disorders and dementia [<xref ref-type="bibr" rid="CR1">1</xref>]. Hypomagnesemia is a known cause of Wernicke`s encephalopathy, and frequently these cases are refractory to treatment with thiamine, as magnesium is a cofactor in thiamine phosphorylation, needed for its activation [<xref ref-type="bibr" rid="CR2">2</xref>]. Our patient developed WE, without an associated Korsakoff syndrome as he did not present with amnesia. These symptoms were completely reversed after two weeks of supplementation with magnesium and thiamine.</p>
      <p>As previously mentioned, magnesium plays a key role in the regulation of the excitability of cell membranes. It antagonizes the NMDA receptor [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>] and cell surface and intracellular voltage-gated calcium channels [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR5">5</xref>], thereby impeding calcium entry to ischemic neurons, which is crucial for the activation of cellular apoptotic pathways. Due to these actions, magnesium has been shown to be a neuroprotective agent in different models of cerebral ischemia, demonstrating improvement of prognosis after a cardiac arrest [<xref ref-type="bibr" rid="CR6">6</xref>], in pre-term infant hypoxic-ischemic injury [<xref ref-type="bibr" rid="CR7">7</xref>], during cardiac by-pass surgery [<xref ref-type="bibr" rid="CR8">8</xref>] and during carotid endarterectomy [<xref ref-type="bibr" rid="CR9">9</xref>]. Nonetheless, recent trials that evaluated intravenous magnesium versus placebo in acute stroke have shown no benefit to this treatment, nor remarkable adverse events [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p>
      <p>According to its cardiovascular functions, magnesium deficiency has been linked to vascular risk factors such as hypertension, atherosclerosis and diabetes, as well as having a statistical association with greater risk of coronary heart disease, myocardial infarction, sudden cardiac death and stroke [<xref ref-type="bibr" rid="CR1">1</xref>]. This ion has direct vasodilatory effects in the cerebral vasculature by antagonizing endothelin-1, neuropeptide Y and angiotensin II, whilst at the same time exerting a calcium antagonist effect on vascular smooth muscle [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. Several trials reported its benefit as a vasodilator agent improving symptomatic vasospasm and delayed ischemia in aneurysmal subarachnoid hemorrhage (SAH) [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>], and for years it was used routinely in the treatment of these problems. However, recent trials evaluated the effect of intravenous magnesium for aneurysmal SAH and showed no benefit in any of their objectives [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]. It is possible that prolonged delay of the administration of magnesium and its limited passage through the blood&#x2013;brain barrier after intravenous supplementation [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR16">16</xref>] have limited its potential benefit. Furthermore, hypomagnesemia has been previously described as a cause of human coronary [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR17">17</xref>] and retinal [<xref ref-type="bibr" rid="CR18">18</xref>] vasospasm, but cerebral vasospasm directly attributable to hypomagnesemia has previously been proven only in animals models [<xref ref-type="bibr" rid="CR19">19</xref>]. This may be because cerebral circulation is less sensitive to variations in magnesium concentrations due to the blood&#x2013;brain barrier, and mild or moderate hypomagnesemia may have no effect on the cerebral vasculature. In the case of our patient, massive vomiting, renal impairment and previous treatment with omeprazole and thiazide lead to a severe hypomagnesemia, which caused secondary vasoconstriction in multiple cerebral arteries, in addition to WE. These disturbances were resolved when serum magnesium levels were normalized, which further confirms the cause-and-effect relationship. It is also possible that adult cyclic vomiting syndrome, which has been associated with autonomic vascular changes [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>], could have played a role in the cerebral vasospasm of the patient, albeit previous studies did not report any cerebrovascular event, so it is difficult to establish a clear association in this case. As to why our patient developed cerebral vasospasm and not vasospasm at other locations remains unknown. In the same way, we cannot give a feasible explanation for why these changes only occurred in the right hemisphere and not in both. Further studies in this area are needed to confirm these hypotheses.</p>
      <p>In conclusion, hypomagnesemia should be considered in the differential diagnosis of patients with neurological symptoms and predisposing causes for magnesium deficit. To the best of our knowledge, we have not found any other reported cases of cerebral vasospasm attributable to hypomagnesemia in humans in the literature. This may be an underdiagnosed condition which should be considered because rapid detection and correction of serum magnesium levels would completely resolve the symptoms. Further studies are needed to confirm these hypotheses.</p>
    </sec>
    <sec id="Sec4">
      <title>Abbreviations</title>
      <p>NIHSS, National Institute of Health Stroke Scale; NMDA, N-methyl-d-aspartate; SAH, subarachnoid hemorrhage; WE, Wernicke&#x2019;s encephalopathy</p>
    </sec>
  </body>
  <back>
    <app-group>
      <app id="App1">
        <sec id="Sec5">
          <title>Additional files</title>
          <p>
            <media position="anchor" xlink:href="12883_2016_660_MOESM1_ESM.jpg" id="MOESM1">
              <label>Additional file 1:</label>
              <caption>
                <p>MRI, axial T1 sequence of the pons, cerebellum and temporal poles showing no abnormalities. (JPG 265&#xA0;kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12883_2016_660_MOESM2_ESM.jpg" id="MOESM2">
              <label>Additional file 2:</label>
              <caption>
                <p>MRI, axial T1 sequence of the pons, cerebellum and temporal poles showing no abnormalities. (JPG 417&#xA0;kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12883_2016_660_MOESM3_ESM.jpg" id="MOESM3">
              <label>Additional file 3:</label>
              <caption>
                <p>MRI, axial T1 sequence of the midbrain, perisylvian spaces and temporo-occipital regions showing no abnormalities. (JPG 395&#xA0;kb)</p>
              </caption>
            </media>
            <media position="anchor" xlink:href="12883_2016_660_MOESM4_ESM.jpg" id="MOESM4">
              <label>Additional file 4:</label>
              <caption>
                <p>MRI, axial T1 sequence of the basal ganglia showing no abnormalities. (JPG 277&#xA0;kb)</p>
              </caption>
            </media>
          </p>
        </sec>
      </app>
    </app-group>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors would like to thank the patient and his family for their cooperation and consent in relation to this study. We also want to thank the Research Committee of the <italic>Gerencia de Atenci&#xF3;n Integrada</italic> of Albacete for the support given for the publication of this article.</p>
      <sec id="FPar1">
        <title>Funding</title>
        <p>None funding declared</p>
      </sec>
      <sec id="FPar2">
        <title>Availability of data and materials</title>
        <p>Data of the clinical history of the patient (discharge summary, blood tests and radiological tests) will not be shared to maintain his anonymity. However, these data are available for review by the by the Editor-in-Chief of this journal.</p>
      </sec>
      <sec id="FPar3">
        <title>Authors&#x2019; contributions</title>
        <p>SGM, FHF, ASL interviewed, diagnosed and treated the patient. JZ, JPR performed the radiological tests, evaluated the neuroimaging findings and gave important clinical opinions. ASL drafted the manuscript. FHF, TS participated in the design of the case report and helped to draft the manuscript. All authors read and approved the final manuscript.</p>
      </sec>
      <sec id="FPar4">
        <title>Competing interests</title>
        <p>The authors declare that they have no competing interests.</p>
      </sec>
      <sec id="FPar5">
        <title>Consent for publication</title>
        <p>Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal. The publication of this manuscript was approved by the Clinical Research Ethics Committee of the Complejo Hospitalario Universitario de Albacete.</p>
      </sec>
      <sec id="FPar6">
        <title>Ethics approval and consent to participate</title>
        <p>Not applicable</p>
      </sec>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gr&#xF6;ber</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kisters</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Magnesium in Prevention and Therapy</article-title>
          <source>Nutrients</source>
          <year>2015</year>
          <volume>7</volume>
          <fpage>8199</fpage>
          <lpage>226</lpage>
          <pub-id pub-id-type="doi">10.3390/nu7095388</pub-id>
          <pub-id pub-id-type="pmid">26404370</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sechi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Serra</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management</article-title>
          <source>Lancet Neurol</source>
          <year>2007</year>
          <volume>6</volume>
          <fpage>442</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="doi">10.1016/S1474-4422(07)70104-7</pub-id>
          <pub-id pub-id-type="pmid">17434099</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chang</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Mack</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Saver</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Sanossian</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Magnesium: potential roles in neurovascular disease</article-title>
          <source>Front Neurol</source>
          <year>2014</year>
          <volume>5</volume>
          <fpage>52</fpage>
          <pub-id pub-id-type="doi">10.3389/fneur.2014.00052</pub-id>
          <pub-id pub-id-type="pmid">24782823</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hanline</surname>
              <given-names>M</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Hypomagnesemia causes coronary artery spasm</article-title>
          <source>JAMA</source>
          <year>1985</year>
          <volume>253</volume>
          <fpage>342</fpage>
          <pub-id pub-id-type="doi">10.1001/jama.1985.03350270036005</pub-id>
          <pub-id pub-id-type="pmid">3965783</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muir</surname>
              <given-names>KW</given-names>
            </name>
          </person-group>
          <article-title>Therapeutic potential of magnesium in the treatment of acute stroke</article-title>
          <source>J Stroke Cerebrovasc Dis</source>
          <year>2000</year>
          <volume>9</volume>
          <fpage>257</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="doi">10.1053/jscd.2000.20669</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Longstreth</surname>
              <given-names>WT</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Fahrenbruch</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Olsufka</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Walsh</surname>
              <given-names>TR</given-names>
            </name>
            <name>
              <surname>Copass</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Cobb</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Randomized clinical trial of magnesium, diazepam, or both after out-of-hospital cardiac arrest</article-title>
          <source>Neurology.</source>
          <year>2002</year>
          <volume>59</volume>
          <fpage>506</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="doi">10.1212/WNL.59.4.506</pub-id>
          <pub-id pub-id-type="pmid">12196641</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rouse</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Hirtz</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Thom</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Varner</surname>
              <given-names>MW</given-names>
            </name>
            <name>
              <surname>Spong</surname>
              <given-names>CY</given-names>
            </name>
            <name>
              <surname>Mercer</surname>
              <given-names>BM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy</article-title>
          <source>N Engl J Med.</source>
          <year>2008</year>
          <volume>359</volume>
          <fpage>895</fpage>
          <lpage>905</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa0801187</pub-id>
          <pub-id pub-id-type="pmid">18753646</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhudia</surname>
              <given-names>SK</given-names>
            </name>
            <name>
              <surname>Cosgrove</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Naugle</surname>
              <given-names>RI</given-names>
            </name>
            <name>
              <surname>Rajeswaran</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lam</surname>
              <given-names>BK</given-names>
            </name>
            <name>
              <surname>Walton</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Magnesium as a neuroprotectant in cardiac surgery: a randomized clinical trial</article-title>
          <source>J Thorac Cardiovasc Surg.</source>
          <year>2006</year>
          <volume>131</volume>
          <fpage>853</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jtcvs.2005.11.018</pub-id>
          <pub-id pub-id-type="pmid">16580444</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mack</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Kellner</surname>
              <given-names>CP</given-names>
            </name>
            <name>
              <surname>Sahlein</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Ducruet</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Mocco</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intraoperative magnesium infusion during carotid endarterectomy: a double-blind placebo-controlled trial</article-title>
          <source>J Neurosurg.</source>
          <year>2009</year>
          <volume>110</volume>
          <fpage>961</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="doi">10.3171/2008.9.17671</pub-id>
          <pub-id pub-id-type="pmid">19199498</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muir</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Lees</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Ford</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial</article-title>
          <source>Lancet</source>
          <year>2004</year>
          <volume>363</volume>
          <fpage>439</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(04)15490-1</pub-id>
          <pub-id pub-id-type="pmid">14962524</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Saver</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Starkman</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Eckstein</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Stratton</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Pratt</surname>
              <given-names>FD</given-names>
            </name>
            <name>
              <surname>Hamilton</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>FAST-MAG Investigators and Coordinators. Prehospital use of magnesium sulfate as neuroprotection in acute stroke</article-title>
          <source>N Engl J Med</source>
          <year>2015</year>
          <volume>372</volume>
          <fpage>528</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMoa1408827</pub-id>
          <pub-id pub-id-type="pmid">25651247</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Veyna</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Seyfried</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Burke</surname>
              <given-names>DG</given-names>
            </name>
            <name>
              <surname>Zimmerman</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Mlynarek</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nichols</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage</article-title>
          <source>J Neurosurg.</source>
          <year>2002</year>
          <volume>96</volume>
          <fpage>510</fpage>
          <lpage>4</lpage>
          <pub-id pub-id-type="doi">10.3171/jns.2002.96.3.0510</pub-id>
          <pub-id pub-id-type="pmid">11883835</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Boet</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Poon</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Gin</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Intravenous magnesium sulfate after aneurysmal subarachnoid hemorrhage: a prospective randomized pilot study</article-title>
          <source>J Neurosurg Anesthesiol.</source>
          <year>2006</year>
          <volume>18</volume>
          <fpage>142</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1097/00008506-200604000-00009</pub-id>
          <pub-id pub-id-type="pmid">16628069</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wong</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Poon</surname>
              <given-names>WS</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Boet</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gin</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ng</surname>
              <given-names>SC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial</article-title>
          <source>Stroke</source>
          <year>2010</year>
          <volume>41</volume>
          <fpage>921</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1161/STROKEAHA.109.571125</pub-id>
          <pub-id pub-id-type="pmid">20378868</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dorhout Mees</surname>
              <given-names>SM</given-names>
            </name>
            <name>
              <surname>Algra</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>WP</surname>
              <given-names>V d t</given-names>
            </name>
            <name>
              <surname>van Kooten</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kuijsten</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Boiten</surname>
              <given-names>J</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomized placebo-controlled trial</article-title>
          <source>Lancet</source>
          <year>2012</year>
          <volume>380</volume>
          <fpage>44</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(12)60724-7</pub-id>
          <pub-id pub-id-type="pmid">22633825</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McKee</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Brewer</surname>
              <given-names>RP</given-names>
            </name>
            <name>
              <surname>Macy</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Phillips-Bute</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Campbell</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Borel</surname>
              <given-names>CO</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Analysis of the brain bioavailability of peripherally administered magnesium sulfate: A study in humans with acute brain injury undergoing prolonged induced hypermagnesemia</article-title>
          <source>Crit Care Med</source>
          <year>2005</year>
          <volume>33</volume>
          <fpage>661</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1097/01.CCM.0000156293.35868.B2</pub-id>
          <pub-id pub-id-type="pmid">15753761</pub-id>
        </element-citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minato</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Katayama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Sakaguchi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Itoh</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Perioperative coronary artery spasm in off-pump coronary artery bypass grafting and its possible relation with perioperative hypomagnesemia</article-title>
          <source>Ann Thorac Cardiovasc Surg</source>
          <year>2006</year>
          <volume>12</volume>
          <fpage>32</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="pmid">16572072</pub-id>
        </element-citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cohen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Laor</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kitzes</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Reversible retinal vasospasm in magnesium-treated hypertension despite no significant change in blood pressure</article-title>
          <source>Magnesium</source>
          <year>1984</year>
          <volume>3</volume>
          <fpage>159</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">6392763</pub-id>
        </element-citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seelig</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Wei</surname>
              <given-names>EP</given-names>
            </name>
            <name>
              <surname>Kontos</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Choi</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Becker</surname>
              <given-names>DP</given-names>
            </name>
          </person-group>
          <article-title>Effect of changes in magnesium ion concentration on cat cerebral arterioles</article-title>
          <source>Am J Physiol</source>
          <year>1983</year>
          <volume>245</volume>
          <fpage>22</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rashed</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Abell</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Familoni</surname>
              <given-names>BO</given-names>
            </name>
            <name>
              <surname>Cardoso</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Autonomic function in cyclic vomiting syndrome and classic migraine</article-title>
          <source>Dig Dis Sci.</source>
          <year>1999</year>
          <volume>44</volume>
          <fpage>74S</fpage>
          <lpage>8S</lpage>
          <pub-id pub-id-type="pmid">10490043</pub-id>
        </element-citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>To</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Issenman</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Kamath</surname>
              <given-names>MV</given-names>
            </name>
          </person-group>
          <article-title>Evaluation of neurocardiac signals in pediatric patients with cyclic vomiting syndrome through power spectral analysis of heart rate variability</article-title>
          <source>J Pediatr.</source>
          <year>1999</year>
          <volume>135</volume>
          <fpage>363</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-3476(99)70135-6</pub-id>
          <pub-id pub-id-type="pmid">10484804</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
